The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Anders Ullén
Stock and Other Ownership Interests - Natera; Pfizer
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; AstraZeneca (Inst); Bristol-Myers Squibb/Pfizer; Janssen-Cilag; Merck KGaA
Research Funding - Merck KGaA (Inst)
 
Christof Vulsteke
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Atheneum; Bayer; Bristol-Myers Squibb/Pfizer; GlaxoSmithKline; ipsen; Janssen; LEO Pharma; MSD; Pfizer
Research Funding - MSD (Inst)
Travel, Accommodations, Expenses - Roche
 
Jens Bedke
Consulting or Advisory Role - Apogepha; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Eisai; Ipsen; Janssen; Merck KGaA; MSD Oncology; Pfizer; Roche
Speakers' Bureau - Apogepha; Astellas Pharma; Bristol-Myers Squibb; Ipsen; Merck KGaA; MSD Oncology; Pfizer
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Ipsen (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst); SeaGen (Inst)
Travel, Accommodations, Expenses - Ipsen (Inst); Merck KGaA (Inst)
 
Steffen Rausch
Honoraria - Advanced Accelerator Applications; Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb/Sanofi; Ipsen; Janssen; Merck; Merck/Pfizer; Novartis
Consulting or Advisory Role - Ambu; AstraZeneca; Bayer; Bristol-Myers Squibb/Sanofi; Eisai; Ipsen; Lilly; Merck Serono; Merck/Pfizer
Speakers' Bureau - Bayer
Research Funding - Ambu
Travel, Accommodations, Expenses - Bayer; ipsen; Janssen; Merck/Pfizer
 
Shilpa Gupta
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb/Medarex; Foundation Medicine; Johnson & Johnson/Janssen; Merck; Natera; Novartis; Pfizer
Research Funding - Acrivon Therapeutics (Inst); Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Convergent Therapeutics (Inst); Exelixis (Inst); Flare Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Tyra Biosciences (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate author royalty
Travel, Accommodations, Expenses - Astellas Pharma; Merck; Pfizer
 
Seok-Ho Kang
Research Funding - Merck
 
Jeanny Aragon-Ching
Honoraria - Astellas Scientific and Medical Affairs Inc; Bristol-Myers Squibb; EMD Serono; Merck KGaA; Merck/Pfizer; Pfizer/EMD Serono
Consulting or Advisory Role - Algeta/Bayer; Amgen; AstraZeneca; AstraZeneca; AstraZeneca/MedImmune; AVEO; Bayer; Dendreon; EMD Serono; Exelixis; Immunomedics; Janssen Biotech; Merck; Novartis; Pfizer; Pfizer/Myovant; Sanofi; Seagen
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Janssen-Ortho; Seattle Genetics/Astellas; Seattle Genetics/Astellas
Travel, Accommodations, Expenses - Algeta/Bayer; Astellas Pharma; Bristol Myers Squibb; Dendreon; EMD Serono
 
Laura Bernal Vaca
Stock and Other Ownership Interests - Idime
Honoraria - Astellas Pharma; AstraZeneca; Bayer; bristol-mayers-squibb; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; Tecnofarma
Consulting or Advisory Role - AstraZeneca; Bayer; Ipsen; Janssen; MSD; Pfizer
Speakers' Bureau - AstraZeneca; Bayer; Bristol-mayers-squibb; Bristol-mayers-squibb; Ipsen; Janssen; MSD
Research Funding - GlaxoSmithKline; MSD
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; Janssen; MSD; Pfizer
 
Viktor Paramonov
Research Funding - MSD
 
Avivit Peer
Honoraria - Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen Oncology; Medison; Merck Serono; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen-Cilag; Merck Serono; MSD Oncology; Novartis; Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; MSD Oncology; Pfizer
 
Viktor Stus
Honoraria - Bionorica
Speakers' Bureau - Bionorica
Research Funding - Merck
Expert Testimony - Bionorica
 
Vagif Atduev
No Relationships to Disclose
 
Keita Nakane
Honoraria - Astellas Pharma; AstraZeneca; Ono Yakuhin; Pfizer; Pfizer; Takeda
 
Jasmine Lichfield
Employment - Astellas Pharma; MSD
Stock and Other Ownership Interests - MSD
 
Changting Meng
Employment - Karyopharm Therapeutics; Pfizer; Seagen
Stock and Other Ownership Interests - Karyopharm Therapeutics; Pfizer; Seagen
Travel, Accommodations, Expenses - Karyopharm Therapeutics; Pfizer; Seagen
 
David Huang
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Chethan Ramamurthy
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Blanca Homet Moreno
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Matthew Galsky
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; EMD Serono; Gilead Sciences; Janssen; Merck; Pfizer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792